{"id":115624,"date":"2020-12-03T10:50:31","date_gmt":"2020-12-03T10:50:31","guid":{"rendered":"http:\/\/ccs-website-wordpress.ind.ninja\/?page_id=115624"},"modified":"2023-09-13T15:20:54","modified_gmt":"2023-09-13T19:20:54","slug":"ccs-bms-pfizer-af-research-award","status":"publish","type":"page","link":"https:\/\/ccs.ca\/ccs-research-awards\/ccs-bms-pfizer-af-research-award\/","title":{"rendered":"The CCS\/BMS-Pfizer Atrial Fibrillation (AF) Research Award"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Since 2015, BMS-Pfizer and the CCS have awarded $2M to 27 early career researchers to support clinical, health services or population health research related to atrial fibrillation<\/a> (AF). These multi-year research projects not only promote excellence in AF research but will ultimately improve the lives of Canadians living with AF.<\/p>\n\n\n\n

AF Award Handbook<\/a><\/p>\n\n\n\n

\n
View Past Recipients<\/a><\/div>\n<\/div>\n\n\n\n
\n\n\n\n

Eligibility<\/span><\/strong><\/p>\n\n\n\n

The principle investigator must:<\/p>\n\n\n\n